<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>All News | HOPO Therapeutics</title>
    <link>/post/</link>
      <atom:link href="/post/index.xml" rel="self" type="application/rss+xml" />
    <description>All News</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2022 HOPO Therapeutics, Inc.</copyright><lastBuildDate>Tue, 01 Mar 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>img/map[gravatar:%!s(bool=false) shape:square]</url>
      <title>All News</title>
      <link>/post/</link>
    </image>
    
    <item>
      <title>Hannah Weber joins HOPO Therapeutics as VP, Strategy &amp; Business Development</title>
      <link>/post/hannah/</link>
      <pubDate>Tue, 01 Mar 2022 00:00:00 +0000</pubDate>
      <guid>/post/hannah/</guid>
      <description>&lt;p&gt;HOPO Therapeutics is thrilled to welcome 
&lt;a href=&#34;../../authors/hannah_weber&#34;&gt;Hannah Weber&lt;/a&gt;
 as our new Vice President of Strategy and Business Development. Formerly a Consultant with L.E.K.&amp;lsquo;s Life Sciences practice in Boston, her industry expertise and commitment to global health make her an exceptional addition to the management team.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>New strategic direction for the company announced</title>
      <link>/post/news2/</link>
      <pubDate>Tue, 23 Nov 2021 00:00:00 +0000</pubDate>
      <guid>/post/news2/</guid>
      <description>&lt;p&gt;In a newsletter sent last week, Julian Rees Ph.D. details a strategic shift in the company&amp;rsquo;s initial focus indication to address childhood lead poisoning, a largely unseen crisis taking place in many disadvantaged communities across the United States and abroad. 
&lt;a href=&#34;https://mailchi.mp/eb4a68f3ad09/exciting-news-from-hopo-therapeutics&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Read&lt;/a&gt;
 the full letter and 
&lt;a href=&#34;../../#contact&#34;&gt;subscribe&lt;/a&gt;
 to future updates!&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>HOPO Therapeutics joins Pad-13 program at Berkeley SkyDeck</title>
      <link>/post/skydeck/</link>
      <pubDate>Thu, 04 Nov 2021 00:00:00 +0000</pubDate>
      <guid>/post/skydeck/</guid>
      <description>&lt;p&gt;We are thrilled to join 
&lt;a href=&#34;https://skydeck.berkeley.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Berkeley SkyDeck&lt;/a&gt;
, the University of California, Berkeley&amp;rsquo;s startup accelerator, as part of their Pad-13 program this fall! SkyDeck&amp;rsquo;s intensive mentorship and training program, as well as their vast network of contacts to industry experts, advisors, and investors, will help accelerate our growth and development over the coming months.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>HOPO Therapeutics team awarded 2021 Bakar Fellowship from UC Berkeley</title>
      <link>/post/bakar/</link>
      <pubDate>Mon, 05 Jul 2021 00:00:00 +0000</pubDate>
      <guid>/post/bakar/</guid>
      <description>&lt;p&gt;The 
&lt;a href=&#34;https://vcresearch.berkeley.edu/bakarfellows/about&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Bakar Fellows Program&lt;/a&gt;
, a highly competitive faculty entrepreneurship initiative at the University of California, Berkeley, has selected the founding team of HOPO Therapeutics, Inc. for their 
&lt;a href=&#34;https://vcresearch.berkeley.edu/bakarfellows/2021-2022-fellows&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;2021 cohort&lt;/a&gt;
. This funding will support research and development activities to further the commercialization of our lead drug compound, 3,4,3,-LI(1,2-HOPO), as well as market and patient research aimed at identifying underlying causes and risk factors for increased retention of gadolinium following MRI contrast administration.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Rebecca Abergel granted tenure</title>
      <link>/post/tenure/</link>
      <pubDate>Thu, 01 Jul 2021 00:00:00 +0000</pubDate>
      <guid>/post/tenure/</guid>
      <description>&lt;p&gt;Co-founder Rebecca Abergel has been promoted to Associate Professor of 
&lt;a href=&#34;https://nuc.berkeley.edu/faculty/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Nuclear Engineering at the University of California, Berkeley&lt;/a&gt;
, and granted tenure. Her research program is colocated at 
&lt;a href=&#34;http://abergel.lbl.gov&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Lawrence Berkeley National Laboratory&lt;/a&gt;
, a US Department of Energy National Laboratory, and focuses on the fundamental, biological, and applied science of heavy metals and radionuclides.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Letter to stakeholders from CEO Julian Rees</title>
      <link>/post/news1/</link>
      <pubDate>Wed, 16 Jun 2021 00:00:00 +0000</pubDate>
      <guid>/post/news1/</guid>
      <description>&lt;p&gt;Co-founder and CEO Julian Rees, Ph.D. sent a letter yesterday with important company news and updates - you can read it 
&lt;a href=&#34;https://mailchi.mp/0c4761470ec9/ceo-letter-june-2021&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;here&lt;/a&gt;
. Join our 
&lt;a href=&#34;../../#contact&#34;&gt;mailing list&lt;/a&gt;
 to stay on top of more news!&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Lanthanide toxicity research highlighted by NPR&#39;s Marketplace, Berkeley Lab</title>
      <link>/post/lanthanide_toxicity2/</link>
      <pubDate>Mon, 07 Jun 2021 00:00:00 +0000</pubDate>
      <guid>/post/lanthanide_toxicity2/</guid>
      <description>&lt;p&gt;Co-founder Rebecca Abergel, Ph.D. 
&lt;a href=&#34;https://www.marketplace.org/2021/04/30/the-u-s-is-trying-to-reclaim-its-rare-earth-mantle/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;spoke to Marketplace&amp;rsquo;s Sabri Ben-Achour&lt;/a&gt;
 about how rare earth elements such as gadolinium are used, produced, and purified.&lt;/p&gt;
&lt;p&gt;Lawrence Berkeley National Laboratory, a Department of Energy National Lab and home to the 
&lt;a href=&#34;http://abergel.lbl.gov&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BioActinide Chemistry group&lt;/a&gt;
, also 
&lt;a href=&#34;https://newscenter.lbl.gov/2021/06/07/heavy-metals-disease-yeast/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;covered this recent discovery&lt;/a&gt;
 and its applications for new discoveries in lanthanide toxicity and human health.&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;HOPO Therapeutics develops safe and orally-available chelating agents that bind to and remove heavy metals from the body. Originally 
&lt;a href=&#34;https://newscenter.lbl.gov/2019/09/12/how-an-anti-nuclear-contamination-pill-could-also-help-mri-patients/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;designed for use in a nuclear disaster scenario&lt;/a&gt;
, new applications for 
&lt;a href=&#34;https://doi.org/10.1038/s41598-018-22511-6&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;exposure to gadolinium&lt;/a&gt;
, 
&lt;a href=&#34;https://doi.org/10.1039/C7NJ04559J&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;lead, cadmium&lt;/a&gt;
, and a range of other heavy metals are being studied. &lt;em&gt;
&lt;a href=&#34;../../science/&#34;&gt;Learn more about our science&lt;/a&gt;
&lt;/em&gt;
&lt;br&gt;
&lt;br&gt;

&lt;a href=&#34;https://doi.org/10.1073/pnas.2025952118&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Original article from the &lt;em&gt;Proceedings of the National Academy of Sciences&lt;/em&gt; here.&lt;/a&gt;
&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>New research details toxicity mechanisms of the lanthanides</title>
      <link>/post/lanthanide_toxicity/</link>
      <pubDate>Wed, 28 Apr 2021 00:00:00 +0000</pubDate>
      <guid>/post/lanthanide_toxicity/</guid>
      <description>&lt;p&gt;The elements of lanthanide series, which are rare earth heavy metals, are increasingly utilized in a range of industries, including consumer electronics, emerging energy technologies, and medicine. While elements such as gadolinium and lanthanum are routinely administered to patients in pharmaceutical products, little is known about their toxicological profile. As human exposure to these elements through both intentional and accidental means continues to rise, 
&lt;a href=&#34;https://doi.org/10.1073/pnas.2025952118&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;studies such as this&lt;/a&gt;
 are essential to understanding, preventing, and treating the negative health outcomes associated with these toxic heavy metals.&lt;/p&gt;
&lt;p&gt;HOPO Therapeutics develops safe and orally-available chelating agents that bind to and remove heavy metals from the body. Originally 
&lt;a href=&#34;https://newscenter.lbl.gov/2019/09/12/how-an-anti-nuclear-contamination-pill-could-also-help-mri-patients/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;designed for use in a nuclear disaster scenario&lt;/a&gt;
, new applications for 
&lt;a href=&#34;https://doi.org/10.1038/s41598-018-22511-6&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;exposure to gadolinium&lt;/a&gt;
, 
&lt;a href=&#34;https://doi.org/10.1039/C7NJ04559J&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;lead, cadmium&lt;/a&gt;
, and a range of other heavy metals are being studied. &lt;em&gt;
&lt;a href=&#34;../../science/&#34;&gt;Learn more about our science&lt;/a&gt;
&lt;/em&gt;
&lt;br&gt;
&lt;br&gt;

&lt;a href=&#34;https://doi.org/10.1073/pnas.2025952118&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Original article from the &lt;em&gt;Proceedings of the National Academy of Sciences&lt;/em&gt; here.&lt;/a&gt;
&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>HOPO-Einsteinium complex published in Nature</title>
      <link>/post/nature/</link>
      <pubDate>Wed, 03 Feb 2021 00:00:00 +0000</pubDate>
      <guid>/post/nature/</guid>
      <description>&lt;p&gt;Designed to selectively chelate the rare earth f-block elements, 3,4,3-LI(1,2-HOPO) - the active ingredient in HOPO Therapeutics&amp;rsquo; lead drug candidate - has allowed researchers in Rebecca Abergel&amp;rsquo;s group at Lawrence Berkeley National Laboratory to provide the first measurements of an einsteinium bond length. It also reinforces the unmatched capability of this chelator to bind f-block metal ions such as gadolinium.&lt;/p&gt;
&lt;p&gt;Originally published in the journal 
&lt;a href=&#34;https://doi.org/10.1038/s41586-020-03179-3&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Nature&lt;/em&gt;&lt;/a&gt;
, additional reporting is available from 
&lt;a href=&#34;https://newscenter.lbl.gov/2021/02/03/discoveries-at-the-edge-of-the-periodic-table-first-ever-measurements-of-einsteinium/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Berkeley Lab&lt;/a&gt;
, 
&lt;a href=&#34;https://www.nbcnews.com/science/science-news/mysterious-radioactive-element-einsteinium-measured-first-time-n1256870&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;NBC News&lt;/a&gt;
, and 
&lt;a href=&#34;https://www.nytimes.com/2021/02/07/science/einsteinium-chemistry-elements.html&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;The New York Times&lt;/em&gt;&lt;/a&gt;

&lt;br&gt;
&lt;br&gt;
&lt;em&gt;
&lt;a href=&#34;../../science/&#34;&gt;Learn more about our science&lt;/a&gt;
&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>HOPO&#39;s chelator featured in Cancer Cytopathology</title>
      <link>/post/acs/</link>
      <pubDate>Tue, 02 Jun 2020 00:00:00 +0000</pubDate>
      <guid>/post/acs/</guid>
      <description>&lt;p&gt;&lt;strong&gt;The development of HOPO Therapeutics&amp;rsquo; lead drug candidate as a medical countermeasure for use in a radiological disaster scenario is detailed in an interview with co-founder 
&lt;a href=&#34;../../authors/rebecca_abergel/&#34;&gt;Rebecca Abergel, Ph.D.&lt;/a&gt;
 in &lt;em&gt;
&lt;a href=&#34;https://doi.org/10.1002/cncy.22298&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Cancer Cytopathology&lt;/a&gt;
&lt;/em&gt;, a journal of the 
&lt;a href=&#34;http://www.cancer.org&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;American Cancer Society&lt;/a&gt;
. An effective treatment for removal of radioactive and other heavy metals from the body, its performance in preclinical trials has been vastly superior to any other chelating agent.&lt;/strong&gt;
&lt;br&gt;
&lt;br&gt;
&lt;em&gt;
&lt;a href=&#34;../../science/&#34;&gt;Learn more about our science&lt;/a&gt;
&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Prior Press Coverage of HOPO&#39;s Foundational Work</title>
      <link>/post/priorpress/</link>
      <pubDate>Sun, 01 Mar 2020 00:00:00 +0000</pubDate>
      <guid>/post/priorpress/</guid>
      <description>&lt;p&gt;&lt;strong&gt;2019&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://news.berkeley.edu/story_jump/five-berkeley-faculty-members-elected-fellows-of-the-aaas/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Rebecca Abergel elected a fellow of the American Association for the Advancement of Science (UC Berkeley)&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://www.dailycal.org/2019/09/15/berkeley-lab-creates-anti-nuclear-contamination-pill-to-help-mri-patients/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Berkeley Lab creates anti-nuclear contamination pill to help MRI patients (The Daily Californian)&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://newscenter.lbl.gov/2019/09/12/how-an-anti-nuclear-contamination-pill-could-also-help-mri-patients/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;A Single Dose for Good Measure: How an Anti-Nuclear-Contamination Pill Could Also Help MRI Patients (Berkeley Lab News)&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2018&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://www.nature.com/articles/s41598-018-22511-6&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Julian Rees and Rebecca Abergel Publish Proof-of-Concept Study Showing Effective Treatment for Gadolinium Contamination&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2013&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://www.innovatorsunder35.com/the-list/rebecca-abergel/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Rebecca Abergel named to MIT Technology Review&amp;rsquo;s list of Innovators Under 35&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2012&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;
&lt;a href=&#34;https://newscenter.lbl.gov/2012/03/06/responding-to-the-radiation-threat/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Responding to the Radiation Threat (Berkeley Lab News)&lt;/a&gt;
&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>HOPO Therapeutics, Inc. is established</title>
      <link>/post/incorporation/</link>
      <pubDate>Thu, 27 Feb 2020 00:00:00 +0000</pubDate>
      <guid>/post/incorporation/</guid>
      <description>&lt;p&gt;&lt;strong&gt;HOPO Therapeutics, Inc. announces incorporation and the appointments of Rebecca J. Abergel, Ph.D., and Julian A. Rees, Ph.D. to the Board of Directors.  Julian A. Rees is also named President and Chief Executive Officer&lt;/strong&gt;&lt;br&gt;
&lt;br&gt;

&lt;a href=&#34;../../authors/rebecca_abergel&#34;&gt;Dr. Abergel&lt;/a&gt;
, Assistant Professor in the Department of Nuclear Engineering at the University of California, Berkeley, and Faculty Scientist in the Chemical Sciences Division at Lawrence Berkeley National Laboratory, is a world-renowned expert in the biological chemistry of the actinide elements.&lt;br&gt;
&lt;br&gt;

&lt;a href=&#34;../../authors/julian_rees&#34;&gt;Dr. Rees&lt;/a&gt;
 joins HOPO Therapeutics as President and Chief Executive Office after a postdoctoral fellowship at Lawrence Berkeley National Laboratory. His research included proof-of-concept and validation studies of HOPO&amp;rsquo;s lead drug candidate for indications related to gadolinium deposition.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
